Title: Observation of clinical effect of budesonide combined with ambroxol atomization inhalation in the treatment of infants with chronic cough caused by pneumonia mycoplasma infection
Abstract: Objective To analyze the clinical effect of budesonide combined with ambroxol atomization inhalation in the treatment of infants with chronic cough caused by pneumonia mycoplasma infection.Methods 100 cases of chronic cough infants caused by PMI were randomly and evenly divided into the test group and the control group.Both groups were given azithromycin anti-infectious treatment and ambroxol HCL ambroxol atomization,and the test group was given budesonide ambroxol atomization additionally.ECP,EOS and T-IgE level of PB were observed before and after the treatment,and the patients′ symptoms relieve-time and relapse times within 3 months were recorded.Results 3 months follow-up after the treatment,ECP,EOS decreased obviously,and IgE increased significantly(P0.05),but there was no significant difference between the two groups.The remission time and disappear time of symptoms and relapse times within 3 months were obviously shorter in the test group than in the control group(P0.05).Conclusion Budesonide combined with ambroxol atomization inhalation has an obvious clinical effect in the treatment of infants with chronic cough caused by pneumonia mycoplasma infection and it is worth to be promoted widely in clinical application.
Publication Year: 2013
Publication Date: 2013-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot